Conservative management of placenta accreta in a multiparous woman

Jennifer C Hunt, Jennifer C Hunt

Abstract

Placenta accreta refers to any abnormally invasive placental implantation. Diagnosis is suspected postpartum with failed delivery of a retained placenta. Massive obstetrical hemorrhage is a known complication, often requiring peripartum hysterectomy. We report a case of presumed placenta accreta in a patient following failed manual removal of a retained placenta. We describe an attempt at conservative management with methotrexate in a stable patient desiring future fertility. Treatment was unsuccessful and led to the development of a disseminated intrauterine infection complicated by a bowel obstruction, requiring both a hysterectomy and small bowel resection. In hemodynamically stable patients, conservative management of placenta accreta may involve leaving placental tissue in situ with subsequent administration of methotrexate. However, ongoing close observation is required to identify complications.

Figures

Figure 1
Figure 1
Transabdominal ultrasound image taken on postpartum day 17. This view of the uterine fundus demonstrates significant persistence of retained placental tissue approximately two weeks after methotrexate administration. Serum βhCG was 1571 UI/L. The distinction between the placental mass (dotted line) and myometrium (asterisk) is shown. Transabdominal ultrasound image taken on postpartum day 24. This view of the uterine fundus shows significant persistence of retained placental tissue approximately three weeks after methotrexate administration. Serum βhCG was 479 UI/L. The distinction between the placental mass (dotted line) and myometrium (asterisk) is depicted.
Figure 2
Figure 2
CT scan of the patient's abdomen on postpartum day 27 demonstrating the uterus with the retained placenta was demonstrated (arrow). The presence of dilated, fluid filled loops of small bowel with collapse of the large bowel confirmed the diagnosis of a mechanical small bowel obstruction. A possible adhesion was noted between the uterine fundus and the bowel (not shown here).

References

    1. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstetrics and Gynecology. 2006;107(4):927–941.
    1. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. American Journal of Obstetrics & Gynecology. 1997;177(1):210–214.
    1. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. American Journal of Obstetrics & Gynecology. 2005;192(5):1458–1461.
    1. Zelop C, Nadel A, Frigoletto FD, Jr., Pauker S, MacMillan M, Benacerraf BR. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein. Obstetrics and Gynecology. 1992;80(4):693–694.
    1. Tong SYP, Tay KH, Kwek YCK. Conservative management of placenta accreta: review of three cases. Singapore Medical Journal. 2008;49(6):e156–e159.
    1. Timmermans S, Van Hof AC, Duvekot JJ. Conservative management of abnormally invasive placentation. Obstetrical and Gynecological Survey. 2007;62(8):529–539.
    1. Kayem G, Davy C, Goffinet F, Thomas C, Clément D, Cabrol D. Conservative versus extirpative management in cases of placenta accreta. Obstetrics and Gynecology. 2004;104(3):531–536.
    1. Bretelle F, Courbière B, Mazouni C, et al. Management of placenta accreta: morbidity and outcome. European Journal of Obstetrics Gynecology and Reproductive Biology. 2007;133(1):34–39.
    1. Sentilhes L, Ambroselli C, Kayem G, et al. Maternal outcome after conservative treatment of placenta accreta. Obstetrics and Gynecology. 2010;115(3):526–534.
    1. Committee on Obstetric Practice. ACOG committee opinion. Placenta accreta. Number 266, January 2002. American College of Obstetricians and Gynecologists. International Journal of Gynecology and Obstetrics. 2002;77(1):77–78.
    1. Rossi AC, Lee RH, Chmait RH. Emergency postpartum hysterectomy for uncontrolled postpartum bleeding: a systematic review. Obstetrics and Gynecology. 2010;115(3):637–644.
    1. Briery CM, Rose CH, Hudson WT, et al. Planned vs emergent cesarean hysterectomy. American Journal of Obstetrics & Gynecology. 2007;197(2):154.e1–154.e5.
    1. Arulkumaran S, Ng CSA, Ingemarsson I, Ratnam SS. Medical treatment of placenta accreta with methotrexate. Acta Obstetricia et Gynecologica Scandinavica. 1986;65(3):285–286.
    1. Winick M, Coscia A, Noble A. Cellular growth in human placenta. I. Normal placental growth. Pediatrics. 1967;39(2):248–251.
    1. Finegold SM, Strong CA, McTeague M, Marina M. The importance of black-pigmented Gram-negative anaerobes in human infections. FEMS Immunology and Medical Microbiology. 1993;6(2-3):77–82.
    1. Matsumura N, Inoue T, Fukuoka M, Sagawa N, Fujii S. Changes in the serum levels of human chorionic gonadotropin and the pulsatility index of uterine arteries during conservative management of retained adherent placenta. Journal of Obstetrics and Gynaecology Research. 2000;26(2):81–87.
    1. Silver LE, Hobel CJ, Lagasse L, Luttrull JW, Platt LD. Placenta previa percreta with bladder involvement: new considerations and review of the literature. Ultrasound in Obstetrics and Gynecology. 1997;9(2):131–138.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi